DD295164A5 - Verfahren zur herstellung von tigogenin-beta-cellobiosid - Google Patents
Verfahren zur herstellung von tigogenin-beta-cellobiosid Download PDFInfo
- Publication number
- DD295164A5 DD295164A5 DD90341563A DD34156390A DD295164A5 DD 295164 A5 DD295164 A5 DD 295164A5 DD 90341563 A DD90341563 A DD 90341563A DD 34156390 A DD34156390 A DD 34156390A DD 295164 A5 DD295164 A5 DD 295164A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- tigogenin
- cellobioside
- formula
- synthesis
- inert solvent
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/12—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Vascular Medicine (AREA)
- Saccharide Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Compounds Of Unknown Constitution (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Mechanical Treatment Of Semiconductor (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/365,588 US5010185A (en) | 1989-06-13 | 1989-06-13 | Processes for tigogenin beta-cellobioside |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD295164A5 true DD295164A5 (de) | 1991-10-24 |
Family
ID=23439483
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD90341563A DD295164A5 (de) | 1989-06-13 | 1990-06-12 | Verfahren zur herstellung von tigogenin-beta-cellobiosid |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US5010185A (cs) |
| EP (1) | EP0403150B1 (cs) |
| JP (1) | JPH0637514B2 (cs) |
| KR (1) | KR920002146B1 (cs) |
| AT (1) | ATE114155T1 (cs) |
| AU (1) | AU619986B2 (cs) |
| CA (1) | CA2018722A1 (cs) |
| CZ (1) | CZ279909B6 (cs) |
| DD (1) | DD295164A5 (cs) |
| DE (1) | DE69014152T2 (cs) |
| DK (1) | DK0403150T3 (cs) |
| ES (1) | ES2063269T3 (cs) |
| FI (1) | FI902937A7 (cs) |
| HU (1) | HU210689B (cs) |
| IE (1) | IE64057B1 (cs) |
| IL (1) | IL94650A (cs) |
| NO (1) | NO902600L (cs) |
| NZ (1) | NZ234028A (cs) |
| PL (3) | PL163259B1 (cs) |
| PT (1) | PT94337A (cs) |
| RU (1) | RU2042688C1 (cs) |
| YU (1) | YU47515B (cs) |
| ZA (1) | ZA904527B (cs) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5294703A (en) * | 1992-05-01 | 1994-03-15 | Eastman Kodak Company | Process for preparing α-D-cellobiose octaacetate |
| AU4044293A (en) * | 1992-06-26 | 1994-01-24 | Pfizer Inc. | Process for steroidal peracyl glycosides |
| AU4226593A (en) * | 1992-06-26 | 1994-01-24 | Pfizer Inc. | Steroidal glycosides for treating hypercholesterolemia |
| FI946081L (fi) * | 1992-06-26 | 1994-12-23 | Pfizer | Steroidaalinen beta-0-sellobiosidihepta-alkanoaattimenetelmä |
| US5530107A (en) * | 1992-10-15 | 1996-06-25 | Pfizer Inc. | Method for making steroidal peracyl glycosides |
| CZ280195A3 (en) * | 1993-04-28 | 1996-02-14 | Pfizer | Crystalline spirostanyl glycoside, monohydrate thereof, pharmaceutical composition based thereon and process for preparing crystalline steroidal glycoside |
| US5502038A (en) * | 1993-06-21 | 1996-03-26 | Medical Research Foundation Of Oregon | Cholesterol sequestrant glycosides that inhibit intestinal cholesterol absorption |
| ES2074006B1 (es) * | 1993-07-05 | 1996-03-16 | Pfizer | Glicosidos esteroidales para tratar hipercolesterolemia. |
| GB9806513D0 (en) * | 1998-03-26 | 1998-05-27 | Phytopharm Ltd | Membrane-bound receptors |
| JP4589869B2 (ja) * | 2002-07-12 | 2010-12-01 | 塩野義製薬株式会社 | 酸触媒として機能するゼオライト類似体の簡易な製造法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4602005A (en) * | 1982-05-17 | 1986-07-22 | Medical Research Foundation Of Oregon | Tigogenin cellobioside for treating hypercholesterolemia and atherosclerosis |
| US4602003A (en) * | 1982-05-17 | 1986-07-22 | Medical Research Foundation Of Oregon | Synthetic compounds to inhibit intestinal absorption of cholesterol in the treatment of hypercholesterolemia |
-
1989
- 1989-06-13 US US07/365,588 patent/US5010185A/en not_active Expired - Fee Related
-
1990
- 1990-06-06 DK DK90306143.0T patent/DK0403150T3/da active
- 1990-06-06 IL IL9465090A patent/IL94650A/en not_active IP Right Cessation
- 1990-06-06 EP EP90306143A patent/EP0403150B1/en not_active Expired - Lifetime
- 1990-06-06 AT AT90306143T patent/ATE114155T1/de not_active IP Right Cessation
- 1990-06-06 ES ES90306143T patent/ES2063269T3/es not_active Expired - Lifetime
- 1990-06-06 JP JP2148456A patent/JPH0637514B2/ja not_active Expired - Lifetime
- 1990-06-06 DE DE69014152T patent/DE69014152T2/de not_active Expired - Fee Related
- 1990-06-11 CZ CS902890A patent/CZ279909B6/cs not_active IP Right Cessation
- 1990-06-11 PT PT94337A patent/PT94337A/pt not_active Application Discontinuation
- 1990-06-11 CA CA002018722A patent/CA2018722A1/en not_active Abandoned
- 1990-06-12 HU HU903816A patent/HU210689B/hu not_active IP Right Cessation
- 1990-06-12 AU AU57079/90A patent/AU619986B2/en not_active Ceased
- 1990-06-12 IE IE210190A patent/IE64057B1/en not_active IP Right Cessation
- 1990-06-12 RU SU904830049A patent/RU2042688C1/ru active
- 1990-06-12 NZ NZ234028A patent/NZ234028A/xx unknown
- 1990-06-12 DD DD90341563A patent/DD295164A5/de not_active IP Right Cessation
- 1990-06-12 PL PL90289136A patent/PL163259B1/pl unknown
- 1990-06-12 KR KR1019900008599A patent/KR920002146B1/ko not_active Expired
- 1990-06-12 YU YU114590A patent/YU47515B/sh unknown
- 1990-06-12 ZA ZA904527A patent/ZA904527B/xx unknown
- 1990-06-12 FI FI902937A patent/FI902937A7/fi not_active IP Right Cessation
- 1990-06-12 PL PL90289135A patent/PL163258B1/pl unknown
- 1990-06-12 PL PL90285593A patent/PL163219B1/pl unknown
- 1990-06-12 NO NO90902600A patent/NO902600L/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69910562T2 (de) | Verfahren zur herstellung von derivaten der 6-cyanomethyl-1,3-dioxan-4-essigsäure | |
| DE2154032A1 (de) | Verfahren zur Demethylierung von 3 Amino Makroliden | |
| CH622529A5 (en) | Process for the preparation of anthracycline glycosides and optically active anthracyclinones | |
| CH634063A5 (de) | Verfahren zur herstellung von furanderivaten. | |
| DD295164A5 (de) | Verfahren zur herstellung von tigogenin-beta-cellobiosid | |
| DD211565A5 (de) | Verfahren zur herstellung von 4"-epi-erythromycin a und derivaten hiervon als brauchbare antibakterielle mittel | |
| EP1197483A2 (de) | Verfahren zur katalytischen Reduktion von Alkinverbindungen | |
| EP0122426B1 (de) | Neue optisch aktive Chromanderivate, Verfahren zu deren Herstellung sowie neue Zwischenprodukte | |
| DE69300551T2 (de) | Verfahren zur Herstellung von (3R,4R)-3-Hydroxy-4-Hydroxymethyl-4-Butanolid. | |
| DE4336155A1 (de) | Verfahren zur Herstellung von L-5-(2-Acetoxy-propionyl-amino)-2,4,6-trijod-isophthalsäure-dichlorid | |
| DE2322655C2 (de) | Prostaglandin F↓2↓↓α↓-ester, Verfahren zu deren Herstellung und deren Verwendung zur Reinigung von Prostaglandin-F↓2↓↓α↓ | |
| DE3124410A1 (de) | Verfahren zur herstellung von isosorbid-2-nitrat | |
| DE1962757C3 (de) | Evomonosid-Derivate, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittel | |
| DE2740950A1 (de) | Verfahren zur herstellung von flavonen | |
| DE2447978C2 (de) | Verfahren zur Herstellung einer Tropan-Verbindung | |
| DE69933672T2 (de) | Verfahren zur herstellung von geschützten dihydroxypropyl-trialkylammoniumsalzen und derivaten davon | |
| DE60030483T2 (de) | Ein verfahren zur herstellung von simvastatin | |
| DE2150146C3 (de) | Verfahren zur Herstellung von Flavon-7-oxyessigsäureäthylester | |
| DE1951294C3 (de) | Verfahren zur Herstellung von 3-Hydroxy-2-methyl-y-pyron (Maltol) | |
| DE69229017T2 (de) | Glyceraldehyd-3-pentanid und Verfahren zu ihrer Herstellung | |
| DE69727680T2 (de) | Stereospezifische Mannosylierung mit hoher Ausbeute | |
| DE69301345T2 (de) | Verfahren zur Herstellung von 4-Deoxy-D-Mannose | |
| DE3242433C2 (cs) | ||
| EP0162235B1 (de) | Enantiomerenreine acetalisch mono-geschützte Diole, deren Herstellung und Verwendung | |
| DE2246867A1 (de) | Tetrahydroxy-bicyclo- eckige klammer auf 3.3.0 eckige klammer zu -octane |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ENJ | Ceased due to non-payment of renewal fee |